IPSC vs PHM · rev $6.6M vs P/E 7.7, rev $17.95B
Century Therapeutics Inc (IPSC) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
IPSC currently screens at market cap $47.8M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the IPSC and PHM stock pages for the full models.
Not investment advice.